EPO Patents = 2

Forward Citations = 12

Loading Chart...

3 inventors (with patents filed for the assignee):

Soon Seog Jeong (5 out of 8 patents)

Ridong Chen (5 out of 10 patents)

Timothy A Mitsky (3 out of 18 patents)

5 patents: Sort by Forward Citations

1. 8771683 - Therapeutic apyrase constructs, apyrase agents, and production methods (2014-07-08),

2. 8535662 - Apyrase therapy for bleeding conditions (2013-09-17),

3. 8021866 - Therapeutic use of ADPase enhanced apyrases (2011-09-20),

4. 7390485 - Design and therapeutic use of adpase enhanced apyrases (2008-06-24),

5. 7247300 - Therapeutic use of soluble CD39L3 (2007-07-24),

Apt Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for rare genetic disorders. Our mission is to improve the lives of patients by delivering cutting-edge treatments that target the underlying causes of their conditions. With a team of experienced scientists and researchers, we are dedicated to advancing the field of precision medicine to provide personalized solutions for patients in need. Visit our website to learn more about our pipeline of potential therapies and our commitment to making a difference in the lives of those affected by rare diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#267 in St. Louis, MO

#697 in Missouri

#50,255 in US

St. Louis, MO, United States of America

Apt Therapeutics, Inc.

Forward Citations = 12

3 inventors:

Soon Seog Jeong (5 out of 8 patents)

Ridong Chen (5 out of 10 patents)

Timothy A Mitsky (3 out of 18 patents)

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com